Cargando…

Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis

OBJECTIVES: The treatment for COVID-19 often utilizes immune-modulating drugs. These drugs are also used in immune mediated inflammatory diseases (IMIDs). We performed a systematic review about seroconversion after SARS-CoV-2 vaccination in patients with IMIDs and impact of various drugs on seroconv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jena, Anuraag, Mishra, Shubhra, Deepak, Parakkal, Kumar-M, Praveen, Sharma, Aman, Patel, Yusuf I., Kennedy, Nicholas A., Kim, Alfred H.J., Sharma, Vishal, Sebastian, Shaji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404391/ https://www.ncbi.nlm.nih.gov/pubmed/34474172 http://dx.doi.org/10.1016/j.autrev.2021.102927

Ejemplares similares

Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis
por: James, Deepak, et al.
Publicado: (2022)

Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta‐analysis
por: Singh, Anupam Kumar, et al.
Publicado: (2021)

Effectiveness and Durability of COVID-19 Vaccination in 9447 Patients With IBD: A Systematic Review and Meta-Analysis
por: Jena, Anuraag, et al.
Publicado: (2022)

Systematic review on failure to adhere to IBD therapies during the COVID-19 pandemic: Correct information is crucial
por: Jena, Anuraag, et al.
Publicado: (2020)

Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic
por: Jena, Anuraag, et al.
Publicado: (2021)

Clinical presentation of COVID-19 in patients with inflammatory bowel disease: a systematic review and meta-analysis
por: Singh, Anupam K., et al.
Publicado: (2022)

Reversing the Tide: Improving the Recruitment of Patients With Inflammatory Bowel Disease in Clinical Trials in the United States
por: Deepak, Parakkal
Publicado: (2020)

Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis
por: Choudhury, Arup, et al.
Publicado: (2022)

Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: a 6-year analysis of the Nationwide Inpatient Sample
por: Stobaugh, Derrick J, et al.
Publicado: (2013)

Safety and efficacy of non-fluoroscopic endoscopic dilatation of gastrointestinal tuberculosis related strictures
por: Kumar, Pankaj, et al.
Publicado: (2022)

COVID-19 and SOS tweets in India
por: Jena, Anuraag
Publicado: (2021)

Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis
por: Kumar-M, Praveen, et al.
Publicado: (2020)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply
por: Alexander, James L, et al.
Publicado: (2021)

A simple point-of-care assay accurately detects anti-spike antibodies after SARS-CoV-2 vaccination
por: Greene, Sarah E., et al.
Publicado: (2023)

Frequency, outcomes, and need for intervention in stricturing gastrointestinal tuberculosis: a systematic review and meta-analysis
por: Jena, Anuraag, et al.
Publicado: (2023)

Clue to the cause of portal hypertension: Look at the raindrops
por: Mishra, Shubhra, et al.
Publicado: (2019)

Stem cell therapy: a novel approach against emerging and re-emerging viral infections with special reference to SARS-CoV-2
por: Khandelwal, Vishal, et al.
Publicado: (2022)

Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope
por: Pal, Deeksha, et al.
Publicado: (2021)

Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2
por: Tripathi, Praveen Kumar, et al.
Publicado: (2020)

Addressing the challenges of the SARS-CoV-2 pandemic in patients affected by autoimmune and rheumatic disease
por: Robinson, Philip C., et al.
Publicado: (2021)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement
por: Alexander, James L, et al.
Publicado: (2021)

Peeling and aspiration of elschnig pearls! An effective alternative to Nd:YAG laser capsulotomy!
por: Bhargava, Rahul, et al.
Publicado: (2013)

Authors’ Reply
por: Bhargava, Rahul, et al.
Publicado: (2014)

SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
por: Gubatan, John, et al.
Publicado: (2020)

Advancement in biosensors for inflammatory biomarkers of SARS-CoV-2 during 2019–2020
por: Garg, Mayank, et al.
Publicado: (2021)

A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels With a Noninvasive Blood Biomarker of Mucosal Remission
por: Gremida, Anas, et al.
Publicado: (2021)

SARS-CoV-2 Vaccines: Types, Working Principle, and Its Impact on Thrombosis and Gastrointestinal Disorders
por: Khare, Shubhra, et al.
Publicado: (2022)

Immunogenicity, breakthrough infection, and underlying disease flare after SARS-CoV-2 vaccination among individuals with systemic autoimmune rheumatic diseases
por: Paik, Julie J., et al.
Publicado: (2022)

The Increased Burden of SARS-CoV-2 Infection in Orthopaedic Trauma Patients: Comparison of Demographics of Both the Waves of the Pandemic—An Indian Tertiary Center Experience
por: Patel, Sandeep, et al.
Publicado: (2021)

Hyperglycemia is associated with duodenal dysbiosis and altered duodenal microenvironment
por: Darra, Aarti, et al.
Publicado: (2023)

Radiographical evaluation of ulcerative colitis
por: Deepak, Parakkal, et al.
Publicado: (2014)

Ustekinumab in treatment of Crohn’s disease: design, development, and potential place in therapy
por: Deepak, Parakkal, et al.
Publicado: (2016)

“Authors’ Reply: Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection”
por: Sood, Mangla, et al.
Publicado: (2021)

A Comprehensive Analysis of Myocarditis in Formerly Healthy Individuals Following SARS-CoV-2 Vaccination (COVID-19 Immunization)
por: Sharma, Kamal, et al.
Publicado: (2022)

PNEUMOPERITONEUM IN SARS-COV-2: A RARE AND OMINOUS CLINICAL SIGN
por: PATEL, SANKALP, et al.
Publicado: (2021)

Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors
por: Chen, Rita E., et al.
Publicado: (2021)

Coronavirus disease - 19 immunity in inflammatory bowel disease patients: The progressive discovery from ignorance
por: Sebastian, Shaji
Publicado: (2023)

Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?
por: Joshi, Gaurav, et al.
Publicado: (2021)

Su1481: IMPACT OF IMMUNOSUPPRESSIVE THERAPIES ON ANTIBODY DECAY FOLLOWING MRNA VACCINATION TO SARS-COV-2 IN A PROSPECTIVE COHORT OF PATIENTS WITH CHRONIC INFLAMMATORY DISEASES
por: Deepak, Parakkal, et al.
Publicado: (2022)

COVID-19 and Menstrual Status: Is Menopause an Independent Risk Factor for SARS Cov-2?
por: Mishra, Neha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5oqttn0fckucn7jresqib33f5o